The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
News|Articles|September 24, 2014
Herpes Zoster Rash
Fluid-filled blisters; necrobiosis lipoidica; gestational diabetes mellitus . . . Test your knowledge on these and other subjects in this quiz.
Advertisement
Question 1:
NEXT QUESTION »
Question 2:
NEXT QUESTION »
Question 3:
NEXT QUESTION »
For the answer, click here.
Question 4:
Several brown, dry, asymptomatic plaques developed on the legs of a 59-year-old woman with diabetes mellitus and pulmonary sarcoidosis. The diagnosis was necrobiosis lipoidica.
NEXT QUESTION »
Question 5:
ANSWER KEY »
ANSWER KEY:
Question 1. G
Question 2. B
Question 3. D
Question 4. F
Question 5. A
Advertisement
Related to this article
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
2
FDA Grants Priority Review to Elinzanetant for VMS in HR+ Breast Cancer Patients on Endocrine Therapy
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
5